Finance

Lists
Why is RPID down ६.७३%?
Dive Deeper
RPID:NASDAQ
Rapid Micro Biosystems, Inc
US$ ०.७४
-६.७३%
(-०.०५३) 1D
US$ ०.७५
+१.७१% (+०.०१३)
Pre-market
Closed: अक्टोबर ३०, १५:००:०१ GMT-५  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for RPID...
Open
US$ ०.७८
High
US$ ०.७९
Low
US$ ०.७०
Mkt. cap
३.६९ करोड
Avg. vol.
२.४३ लाख
Volume
०.००
52-wk high
US$ ४.९४
52-wk low
US$ ०.७०
EPS
-US$ १.११
Beta
१.५०
Shares outstanding
४.५७ करोड
No. of employees
१७१
Open
US$ ०.७८
High
US$ ०.७९
Low
US$ ०.७०
Mkt. cap
३.६९ करोड
Avg. vol.
२.४३ लाख
Volume
०.००
52-wk high
US$ ४.९४
52-wk low
US$ ०.७०
EPS
-US$ १.११
Beta
१.५०
Shares outstanding
४.५७ करोड
No. of employees
१७१
News stories
From web sources and news partners
FXStreet
FXStreet
·
३० मिनेट पहिले
Dow Jones futures advance as risk appetite rebounds ahead of busy week
The New York Times
The New York Times
·
७ घण्टा पहिले
After Tech Sell-Off, Investors Brace for More Market Volatility
About Rapid Micro Biosystems, Inc
CEO-
Employees१७१
Founded२००६
HeadquartersLowell, म्यासेचुसेट्स, संयुक्त राज्य अमेरिका
Sector-
Analyst ratings
Based on 3 analysts giving stock ratings to RPID in the past 3 months
Strong buy
Buy
3
Hold
0
Sell
0
12-month forecast
Based on 3 Wall Street analysts offering 12 month price targets for RPID in the last 3 months.
Highest
Current US$ ०.७४
US$ ८.०० (+९८७.१०%)
Average
US$ ६.०० (+७१५.३३%)
Lowest
US$ ३.०० (+३०७.६६%)
Analyst
Recommendation
Action
Price target
Projected
Date
Max Masucci
Roth MKM
Buy
Initiated
US$ ३.००
+३०७.७%
09/29/2026
Thomas Flaten
Lake Street
Buy
Maintained
US$ ७.००
+८५१.२%
08/10/2026
Daniel Arias
Stifel Nicolaus
Buy
Maintained
US$ ८.००
+९८७.१%
08/10/2026
Paul Knight
KeyBanc
Buy
Maintained
US$ ५.००
+५७९.४%
05/29/2026
Brendan Smith
TD Cowen
Buy
Maintained
-
-
05/27/2026
Previous reportsAll values in USD
Loading Previous Earnings...
Revenue
Net income
All values in USD
२०२५ सेप्टेम्बर
२०२५ डिसेम्बर
२०२६ मार्च
२०२६ जुन
Revenue
७८.३८ लाख
१.१३ करोड
८०.०२ लाख
८०.५४ लाख
Cost of goods sold
७१.४२ लाख
१.१६ करोड
७६.३१ लाख
६८.४२ लाख
Cost of revenue
७१.४२ लाख
१.१६ करोड
७६.३१ लाख
६८.४२ लाख
Research and development expenses
३५.२९ लाख
३२.२० लाख
३३.५९ लाख
३३.३२ लाख
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
८५.३९ लाख
८६.६३ लाख
१.०९ करोड
१.०२ करोड
Operating expense
१.२१ करोड
१.१९ करोड
१.४२ करोड
१.३५ करोड
Total operating expenses
१.९२ करोड
२.३५ करोड
२.१९ करोड
२.०४ करोड
Operating income
-१.१४ करोड
-१.२२ करोड
-१.३९ करोड
-१.२३ करोड
Other non operating income
-७९.०० हजार
८०.०० हजार
-३२.०० हजार
-५०.०० हजार
EBT including unusual items
-१.१५ करोड
-१.२५ करोड
-१.४३ करोड
-१.२९ करोड
EBT excluding unusual items
-१.१५ करोड
-१.२५ करोड
-१.४३ करोड
-१.२९ करोड
Income tax expense
८.०० हजार
१४.०० हजार
८.०० हजार
४५.०० हजार
Effective tax rate
-०.०७%
-०.११%
-०.०६%
-०.३५%
Other operating expenses
-
-
-
-
Net income
-१.१५ करोड
-१.२५ करोड
-१.४३ करोड
-१.२९ करोड
Net profit margin
-१४६.७८%
-११०.७७%
-१७८.३९%
-१६०.४५%
Earnings per share
-०.२६
-०.२८
-०.३१
-०.२७
Interest and investment income
३.४७ लाख
३.२१ लाख
२.५६ लाख
१.४० लाख
Interest expense
-३.९३ लाख
-६.७३ लाख
-६.३९ लाख
-६.४६ लाख
Net interest expenses
-४६.०० हजार
-३.५२ लाख
-३.८३ लाख
-५.०६ लाख
Depreciation and amortization charges
-
-
-
-
EBITDA
-१.०७ करोड
-१.१६ करोड
-१.३१ करोड
-१.१६ करोड
Gain or loss from assets sale
-
-
-
-
Insider transactions
Insider transactions data is drawn from third-party sources. Learn more
Insider
Position
Type
Date
Shares
Amount
Page 1
Upcoming events
AI content may include mistakes. Learn more
Google एपहरू